[PDF] Top 20 Rev. Bras. Psiquiatr. vol.26 suppl.1 en a04v26s1

... The classifications of the DSM-III R, DSM-IV and the ICD 10 have similar criteria for alcohol dependence (Table 1). The same does not occur, however, with the diagnosis of harmful use. A common point between these ... See full document

... were shown to have anxiolytic effects in the treatment of cannabis dependence and to function as an adjuvant in the treatment of schizophrenia, although additional studies are necessary to support this finding. ... See full document

... could 1) attenuate symptoms of withdrawal, 2) might blunt the reinforcing effects of cannabis, or 3) reduce cravings or urges for cannabis ...CB 1 receptor antagonists, medications that block the receptor ... See full document

... Younger individuals that use cannabis are more vulnerable to the development of psychiatric disorders, with an increased risk for suffering the adverse consequences [r] ... See full document

... Cognitive impairment in cannabis users is most often detected in memory, attention and inhibitory control and executive functions. There is no doubt that the endogenous cannabinoid system plays a critical role in these ... See full document

... the confounding effects of concomitant use of other drugs of abuse, pre-morbid personality traits, and cannabis use as a form of self-medication of schizophrenia. The adjusted odds ratio for cannabis use predating ... See full document

... CB 1 is primarily localized at presynaptic nerve terminals and accounts for the majority of neurobehavioural effects of ...CB 1 and CB 2 are arachidonic acid ... See full document

... A somewhat clearer picture appears in posttraumatic stress disorder (PTSD). A considerable amount of work, from various groups and in different countries, has shown that in animal studies CB 1 signaling is ... See full document

... 1. Belmaker RH. Bipolar Disorder. New Engl J Med. 2004; 351:476-89. Beny Lafer Beny Lafer Beny Lafer Beny Lafer Beny Lafer Jair C Soares Jair C Soares Jair C Soares Jair C Soares Jair C Soares Marsal Sanches ... See full document

... The present study aims to present the main clinical characteristic of the disorder in children and adolescents, as well as the nomenclature, description of clinical phenotypes and the mo[r] ... See full document

... 12. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol. 1992;12(1 Suppl):42S-52S. Review. 13. ... See full document

... between mood and anxiety disorders, claiming that the association is probably not a measure of the frequency in which two independent morbid conditions coexist, but rather a result of an artifact of the categorical ... See full document

... 33. Nath J, Sagar R. Late onset bipolar disorder due to hyperthyroidism. Acta Psychiatr Scand. 2001;104(1):72-5; discusion p.74-5. 34. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. ... See full document

... 1. Blazer DG. Mood disorders: epidemiology. In: Sadock BJ, Sadick VA, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins, c2000. p. ... See full document

... The concept that we currently define as bipolar disorder dates from the 19th century and is intimately related to the appearance of one or more episodes of mania over the course of a lifetime. As early as 1854, Falret ... See full document

... 43. Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J, et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry. 1999;4(1):76-84. ... See full document

... 25. Keller MB, Lavori PW, Coryell W, Endicott J, Muellert TI. Bipolar I: a 5- year prospective follow up. J Affect Disord. 1993;181:243-5. 26. Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, et ... See full document

... 6. Saito VM, Wotjak CT, Moreira FA. Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? Rev Bras Psiquiatr. ... See full document

... 32. Boggio PS, Bermpohl F, Vergara AO, Muniz AL, Nahas FH, Leme PB, Rigonatti SP, Fregni F. Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in ... See full document

... Note: This supplement has chosen the word Transtorno Invasivo de Desenvolvimento (TID) in detriment of the other two translations which have been used in Portuguese for the expression Pervasive Developmental Disorder ... See full document